Literature DB >> 3123475

Type IX collagen proteoglycan from cartilage is covalently cross-linked to type II collagen.

M van der Rest1, R Mayne.   

Abstract

Type IX collagen is a recently described component of cartilage. This nonfibril-forming molecule is composed of three helical (COL1-COL3) and four nonhelical domains (NC1-NC4) and also serves as a core protein for a single glycosaminoglycan side chain. To understand its spatial relationship with other matrix constituents, a peptide containing a lysine-derived cross-link was isolated and subjected to amino acid sequencing. The results show that type IX collagen is linked to type II collagen by a hydroxypyridinium cross-link. This cross-link connects the central triple helical (COL2) domain of one alpha 2(IX) chain to the amino telopeptides of two alpha 1(II) chains. The cross-link is very close to the glycosaminoglycan attachment site found in the nonhelical NC3 domain of the alpha 2(IX) chain. A model of the resulting assembly suggests that type IX collagen is located at the surface of the fibril with the short COL 3 domain and the basic globular NC4 domain projecting out from the surface of the fibril. The NC4 domain could, therefore, serve as a binding site for other matrix constituents. In this model, the glycosaminoglycan chain of type IX collagen would be located at the gap region of the fibril.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123475

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  A degeneration-based hypothesis for interpreting fibrillar changes in the osteoarthritic cartilage matrix.

Authors:  N Broom; M H Chen; A Hardy
Journal:  J Anat       Date:  2001-12       Impact factor: 2.610

2.  Corneal collagen fibril structure in three dimensions: Structural insights into fibril assembly, mechanical properties, and tissue organization.

Authors:  D F Holmes; C J Gilpin; C Baldock; U Ziese; A J Koster; K E Kadler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

3.  A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy.

Authors:  C G Bönnemann; G F Cox; F Shapiro; J J Wu; C A Feener; T G Thompson; D C Anthony; D R Eyre; B T Darras; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

4.  An immunohistochemical study of the distribution of matrical proteins in the mandibular condyle of neonatal mice. I. Collagens.

Authors:  M Silbermann; K von der Mark
Journal:  J Anat       Date:  1990-06       Impact factor: 2.610

5.  The NC2 domain of collagen IX provides chain selection and heterotrimerization.

Authors:  Sergei P Boudko; Keith D Zientek; Jesse Vance; Jessica L Hacker; Jürgen Engel; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

6.  A short isoform of Col9a1 supports alveolar bone repair.

Authors:  K Ting; H Ramachandran; K S Chung; N Shah-Hosseini; B R Olsen; I Nishimura
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

7.  Electron-microscopic localization of type II, IX, and V collagen in the organ of Corti of the gerbil.

Authors:  N B Slepecky; J E Savage; L K Cefaratti; T J Yoo
Journal:  Cell Tissue Res       Date:  1992-03       Impact factor: 5.249

8.  Bovine cartilage types VI and IX collagens. Characterization of their forms in vivo.

Authors:  S Ayad; A Marriott; K Morgan; M E Grant
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

9.  Immunohistochemical localization of articular cartilage proteoglycan and link protein in situ using monoclonal antibodies and lectin-binding methods.

Authors:  S Hoedt-Schmidt; J McClure; M K Jasani; D A Kalbhen
Journal:  Histochemistry       Date:  1993-05

10.  Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease.

Authors:  R Fässler; P N Schnegelsberg; J Dausman; T Shinya; Y Muragaki; M T McCarthy; B R Olsen; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.